As of 2025-09-19, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (88.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.75 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -852.6%.
The range of the Relative Valuation is (84.14) - (89.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 19.3x | 18.4x |
| Forward P/E multiples | 18.1x - 21.4x | 19.5x |
| Fair Price | (84.14) - (89.64) | (88.43) |
| Upside | -816.1% - -862.9% | -852.6% |
| Date | P/E |
| 2025-09-16 | -2.36 |
| 2025-09-15 | -2.47 |
| 2025-09-12 | -2.54 |
| 2025-09-11 | -2.59 |
| 2025-09-10 | -2.65 |
| 2025-09-09 | -2.77 |
| 2025-09-08 | -2.67 |
| 2025-09-05 | -2.65 |
| 2025-09-04 | -2.58 |
| 2025-09-03 | -2.55 |
| 2025-09-02 | -2.55 |
| 2025-08-29 | -2.62 |
| 2025-08-28 | -2.66 |
| 2025-08-27 | -2.67 |
| 2025-08-26 | -2.70 |
| 2025-08-25 | -2.49 |
| 2025-08-22 | -2.56 |
| 2025-08-21 | -2.35 |
| 2025-08-20 | -2.28 |
| 2025-08-19 | -2.23 |
| 2025-08-18 | -2.17 |
| 2025-08-15 | -2.20 |
| 2025-08-14 | -2.25 |
| 2025-08-13 | -2.25 |
| 2025-08-12 | -2.23 |
| 2025-08-11 | -2.21 |
| 2025-08-08 | -2.09 |
| 2025-08-07 | -2.02 |
| 2025-08-06 | -1.87 |
| 2025-08-05 | -1.80 |
| 2025-08-04 | -1.86 |
| 2025-08-01 | -1.79 |
| 2025-07-31 | -1.83 |
| 2025-07-30 | -1.87 |
| 2025-07-29 | -1.85 |
| 2025-07-28 | -1.89 |
| 2025-07-25 | -2.07 |
| 2025-07-24 | -1.94 |
| 2025-07-23 | -1.84 |
| 2025-07-22 | -1.70 |
| 2025-07-21 | -1.68 |
| 2025-07-18 | -1.71 |
| 2025-07-17 | -1.79 |
| 2025-07-16 | -1.79 |
| 2025-07-15 | -1.83 |
| 2025-07-14 | -1.95 |
| 2025-07-11 | -1.97 |
| 2025-07-10 | -2.08 |
| 2025-07-09 | -2.01 |
| 2025-07-08 | -1.94 |